Applications are invited for a Director of Palliative Care and Section Head within the Division of Hematology/Oncology, Knight Cancer Institute of Oregon Health & Science University, Portland, Oregon, a NCI Designated Comprehensive Cancer Center. The successful candidate will have an established track record of leadership within the field and a commitment to driving advances in the field. They will join an internationally recognized program whose current Director is assuming a Directorship position with Atul Gawande at Harvard. The OHSU Palliative Care Program is robust, and is an integral part of the missions of the OHSU Hospital, the Division and the Knight Cancer Institute. The Knight Cancer Institute has created an environment that has attracted highly driven and talented visionaries, who together are changing the way we take of people with life threatening diseases. As one of the nation’s top twenty biomedical research institutions, OHSU offers a highly collaborative atmosphere in the context of a comprehensive health care focused university, with particular expertise in cancer, neurosciences, and cardiovascular medicine. Portland is consistently ranked one of the most desirable places to live, and offers ready access to a vibrant city as well as a vast array of outdoor activities. Together, this opportunity offers a highly nurturing environment to grow professionally and personally. Applicants should provide a one-page statement of research interests and objectives with their curriculum vitae, addressed to Raymond Bergan, MD, Chief, Division of Hematology/Oncology. For more information and to apply online, please visit our website at www.ohsujobs.com, and reference recruitment IRC57036. OHSU is an equal opportunity, affirmative action employer.
Required: MD, MD/PhD. Licensed to practice medicine in Oregon; Board certified in Hospice/Palliative Medicine. The ideal applicant demonstrates the background, focus and drive to excel, as well as the desire to deliver the best care possible to palliative care patients in a clinical research environment. • Board certified in Hospice/Palliative Medicine • At least 1 year experience working as part of an interdisciplinary team. • Current state medical or nursing license and in good standing with medical/nursing board. • Palliative Medicine fellowship training, management and leadership experience preferred. • Five (5) years clinical experience beyond board certification and 1 year of administrative experience preferred • Has achieved objective measures of leadership
Oregon Health & Science University is a nationally recognized health and research university. With over 14,000 employees, OHSU is one of the state’s largest employers, providing excellent job opportunities, career growth and a very competitive total rewards package. OHSU is located in beautiful Portland, which is consistently ranked one of the most desirable places to live, and offers ready access... to a vibrant city as well as a vast array of outdoor activities.
The Knight Cancer Institute at OHSU is an international leader in cancer research and precision treatment. Our institute’s director, Brian Druker, M.D., helped usher in the era of precision cancer medicine with research that led to the breakthrough drug Gleevec®. The Knight Cancer Institute is the only National Cancer Institute (NCI)-designated Cancer Center between Sacramento and Seattle, an honor earned only by the nation's top cancer centers. It is also the headquarters for the NCI’s SWOG collaborative, a cancer research cooperative group that designs and conducts multidisciplinary clinical trials to improve the practice of medicine.
The Knight Cancer Institute has attracted both public support and private philanthropy to build upon its scientific and clinical leadership. Most recently, it completed a campaign to raise $1 billion in new funding to expand its expertise in precision medicine with a plan to improve the early detection of lethal forms of the disease. These collaborations have enabled the OHSU Knight Cancer Institute to recruit and retain some of the world’s top scientists and clinicians to pursue its comprehensive strategy.